Skip to main content
Top
Published in: Reactions Weekly 1/2021

01-11-2021 | Lymphoma | Case report

Insulin/semaglutide

Various toxicities: 5 case reports

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Rajamand Ekberg N, et al. Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Denmark/Sweden multicentre, prospective, observational study. Primary Care Diabetes 15: 871-878, No. 5, Oct 2021. Available from: URL: http://doi.org/10.1016/j.pcd.2021.06.008 Rajamand Ekberg N, et al. Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Denmark/Sweden multicentre, prospective, observational study. Primary Care Diabetes 15: 871-878, No. 5, Oct 2021. Available from: URL: http://​doi.​org/​10.​1016/​j.​pcd.​2021.​06.​008
Metadata
Title
Insulin/semaglutide
Various toxicities: 5 case reports
Publication date
01-11-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-06163-9

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Triamcinolone